The Worlds #1 Renewable Energy Network for News & Information
Sign In
or
Register
Sections
Home
Solar
Wind
Geothermal
Bio
Hydro
Careers
Companies
Webcasts
White Papers
Magazines
Awards
Account
Sign In
Register
Search
REW 40 Index
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Merck & Co., Inc.
(NY:
MRK
)
47.16
USD
-0.17 (-0.36%)
Official Closing Price
/ Updated:
6:40 PM EDT, May 24, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
15,795,941
Open
47.05
Bid (Size)
47.08 (100)
Ask (Size)
47.23 (100)
Prev. Close
47.33
Today's Range
46.60 - 47.16
52wk Range
37.02 - 48.79
Shares Outstanding
3,019,611,844
Dividend Yield
3.60%
Top News
More News
AtheroNova Mentioned by Analyst in Life Sciences Report
May 24, 2013
from
ACCESSWIRE
Two ways to pick your summer stock retreat
May 24, 2013
By John Wasik (Reuters) – It used to be easy to abide by the old Wall Street nugget that you should pull out of the market in spring and come back in the fall. But research shows that it doesn’t make...
Read More
category
XLB
,
XLE
,
NYA
, and 18 more.
from
Retirement Investments -- MyPlanIQ » Headline
More News
Read More
Secrets to Making Money in CLWR, MS, MRK and KWK
May 24, 2013
from
Marketwired News Releases
UPDATE 2-Boy Scouts of America votes to end century-old ban on gay scouts
May 23, 2013
category
companyNews
from
Reuters: Company News
Merck halts development of experimental Parkinson's drug
May 23, 2013
category
companyNews
from
Reuters: Company News
Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will Discontinue
May 23, 2013
from
StreetInsider.com News Articles
Merck Issues Update on Phase III Trial for Preladenant
May 23, 2013
category
Benzinga
,
News
,
MRK
, and 1 more.
from
Latest Articles from Benzinga.com
Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational Parkinson’s Disease Medicine
May 23, 2013
from
Business Wire News Releases
Corporate Stock Buybacks Driving Today's Action?
May 23, 2013
from
StreetInsider.com News Articles
Inside Merck's new crusade against cervical cancer in Africa
May 23, 2013
category
Health Care
,
Bill and Melinda Gates Foundation
,
U/S/ Food and Drug Administration
, and 4 more.
from
Business Journals
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here